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Introduction
Vascular development within the brain and retina depends upon interactions of vascular cells with neighboring cells and extracellular matrix (ECM). These cells secrete growth factors, such as vascular endothelial growth factor (VEGF) and TGF␤, which are essential for vascular growth and stability. Integrins are cellsurface proteins implicated in numerous aspects of vascular development. Of particular interest are the ␣V-containing integrins, several of which promote activation of TGF␤ (Glinka et al., 2011; Shi et al., 2011) , which in turn regulates differentiation of endothelial cells and pericytes (Carmeliet and Jain, 2011) .
In the nervous and immune systems, the integrin ␣V␤8 is an important regulator of TGF␤ (Yang et al., 2007; Mu et al., 2008; Aluwihare et al., 2009 ). Binding of ␣V␤8 to an RGD site in the latent complex of TGF␤ results in release of the active protein (Mu et al., 2002; Cambier et al., 2005) . In contrast to other integrins, ␣V␤8 is likely to be constitutively active (Helsten et al., 2008) . Thus, regulation of ␣V␤8-dependent TGF␤ activation likely depends on control of integrin expression levels as well as the presence other TGF␤ latent complex-binding proteins, such as neuropilins, or proteases that cooperate with this integrin (Glinka et al., 2011; Shi et al., 2011) .
In the absence of ␣V␤8, vascular development in the brain is highly abnormal with elevated proliferation, impaired organization of endothelial cells and extensive hemorrhage, phenotypes mimicked by combined TGF␤1 and 3 mutation (McCarty et al., 2002; Zhu et al., 2002; Aluwihare et al., 2009 ). During brain vascular development, ␣V␤8 appears to be required on neuroepithelial cells, but not pericytes or endothelial cells (McCarty et al., 2005; Proctor et al., 2005) . It is thought that neuroepithelialderived ␣V␤8 activates ECM-sequestered TGF␤, which then has direct effects on surrounding vessels.
Prior work showed that TGF␤ signaling is required to maintain retinal vascular stability and retinal function in adult mice (Walshe et al., 2009) , and TGF␤ signaling has been implicated in several retinal diseases (Carmeliet and Jain, 2011) . It is therefore important to understand how TGF␤ signaling in the retina is regulated.
In this paper, we characterize the role of ␣V␤8-TGF␤ signaling in murine retinal vascular development. Our results show that deletion of the Itgb8 gene from retinal ganglia cells and Mül-ler glia, but not astrocytes, results in highly abnormal vascular patterning and instability. An almost identical phenotype results from genetic removal of TGF␤1 from the retina. Our results show that deletion of Itgb8 results in decreased phosphorylation of SMAD3 in retinal vascular endothelial cells, and specific removal of the TGF␤RII receptor from these cells recapitulates the major deficits observed in Itgb8 and Tgfb1 mutants. In addition, retinal deletion of Itgb8, Tgfb1, or Tgfbr2 also dramatically impairs formation of the retina's outer deep vascular plexus, as was previously seen following inhibition of neuropilin-1, a receptor previously implicated in TGF␤ activation and signaling (Cao et al., 2010; Glinka et al., 2011) .
Materials and Methods
Mice. To generate heterozygous Itgb8icr mice, Itgb8 ϩ/Ϫ mice (Zhu et al., 2002) bred on a C57BL/6129S4 genetic background, were backcrossed for two generations with the ICR/CD-1 outbred strain. Itgb8icr ϩ/Ϫ heterozygotes were then bred to generate mutant Itgb8icr Ϫ/Ϫ (␤8icr
), mouse pups and Itgb8icr ϩ/ϩ littermate controls, which were used for experiments. To specifically delete Itgb8 from retinal neuroepithelium including Müller glia, we used the nesCre mouse line (also known as NesCre8 (Petersen et al., 2002) . Itgb8 flox/flox females (Proctor et al., 2005) were crossed with Itgb8 flox/ϩ ;NesCre tg/ϩ males to obtain Itgb8 flox/flox ; NesCre tg/ϩ mutant pups (␤8;nesCre) and Itgb8
;NesCre tg/ϩ littermate controls. To target retinal astrocytes for recombination, we used the mGFAP-Cre line 73.12 (Garcia et al., 2004) .
Tgfb1 heterozygotes (Tgfb1 ϩ/Ϫ ) were bred on an NIH/Ola background, and then were intercrossed to generate mutant homozygousnull Tgfb1 Ϫ/Ϫ mice. To conditionally delete Transforming Growth Factor ␤ Receptor II (Tgfbr2) from retinal vascular endothelial cells, we crossed Tgfbr2 flox/flox female mice (Levéen et al., 2002) with PlateletDerived Growth Factor-B (Pdgfb)-inducible Cre tg/ϩ -iCreER TM2 mice (Claxton et al., 2008 (Srinivas et al., 2001) , or ROSA26tm14(CAGtdTomato) (Ai14) (Madisen et al., 2010) ;PdgfbiCreER TM2 littermate controls were used. Tgfbr2 inactivation was induced by intragastric injection of 50 l of tamoxifen solution (Sigma, T5648 -1G, 1 mg/ml, generated by diluting a 10 mg/ml tamoxifen stock solution in 1:4 ethanol/corn oil with corn oil) once daily on postnatal day 1 (P1), P2, and P3 (for analysis at P6), or P5 and P6 (for analysis at P9). A hypodermic 27 G needle was used to administer tamoxifen solution. "TGF␤RII;i⌬EC" refers to Tgfbr2 flox/flox ;Pdgfb-iCreER TM2 mutants after administration of tamoxifen. Inducible genetic experiments were performed under UCSF IACUC-approved guidelines.
Immunohistochemistry. Pups of the described crosses were killed and dissected at P6, P9, or P14 for investigation of retinal primary vascular plexus sprouting angiogenesis (P6) and deeper plexus vasculogenesis (P9, P14) (Pitulescu et al., 2010) . For retina whole mounts, dissected eyes underwent weak fixation (for ease of hyaloid vasculature removal) in ϳ2 ml of 4% paraformaldehyde (PFA) in PBS for 1 h on ice. Dissected retinas were further fixed at 4°C overnight in 4% PFA in PBS, and then stored at 4°C in PBS. Whole retinas were blocked in 5% BSA, 0.3% Triton X-100 in PBS (block buffer) overnight at 4°C before isolectin incubation and antibody administration. For isolectin labeling, retinas were transferred to Pblec buffer (PBS, pH 6.8, containing, in mM: 1 CaCl 2, 1 MgCl 2, 0.1 MnCl 2, 1% Triton X-100) and then stained with isolectin B4 (IB4) overnight as previously described (Pitulescu et al., 2010) . The following day, primary antibody labeling was performed in block buffer overnight at 4°C. After primary antibody incubation, retinas were labeled with SA-647 or SA-488 and fluorophore-conjugated secondary antibodies in block buffer for 2 h at room temperature. Stained whole retinas were flat-mounted with Prolong Gold (Invitrogen). For thin sectioning, whole eyes were fixed in 4% PFA overnight, then transferred to 30% sucrose in PBS overnight. Eyes were embedded in OCT then cryosectioned at 15 m. Cryosections were permeabilized and blocked with 0.3% Triton X-100 and 3% BSA in PBS. Sections were incubated with primary antibodies overnight at 4°C, then with fluorophore-conjugated secondary antibodies (Invitrogen) and ToPro3 (Invitrogen) nuclear stain and then mounted with Prolong Gold (Invitrogen).
Antibodies. Primary antibodies used were: monoclonal rat anti-CD31 clone MEC13.3 (BD PharMingen, 550274, 1:100), polyclonal rabbit antimouse Collagen IV (AbD Serotec, 2150-1470, 1:100), monoclonal mouse anti-␣ Smooth Muscle Actin Clone 1A4 (Sigma, A 2547, 1:100), monoclonal rat anti-mouse TER-119 Erythroid Antigen Antibody (R&D Systems, MAB1125, 1:100), polyclonal rabbit anti-phospho Histone H3 (Ser10) (Millipore, 06 -570, 1:100), polyclonal rabbit anti-Glial Fibrillary Acidic Protein (Dako Cytomation, Z 0334, 1:100), monoclonal mouse anti-rat nestin clone rat-401 (4d4) (AbD Serotec, 21263, 1:100), polyclonal rabbit anti-glutamine synthetase (Thermo Scientific PA1-46165, 1:250), monoclonal mouse anti-Cellular Retinaldehyde-Binding Protein (Novus Biologicals, (B2) NB100-74392, 1:250), monoclonal rabbit antiphospho-SMAD3 (Epitomics, 1:100) biotinylated GSL I-isolectin B4 (Vector Laboratories, B-1205, 1:25), mouse. Conjugated rabbit anti-GFP-Alexa Fluor 488 (1:100) was used to amplify endogenous eYFP signal from Rosa26 EYFP Cre reporter mice. Secondary antibodies used were: Alexa Fluor 488-or 647-conjugated goat anti-rat (Invitrogen, A21311 or A31852, 1:100), Alexa Fluor 555-conjugated goat anti-rabbit (Invitrogen, A31851, 1:100) and Alexa Fluor 488-, 555-, or 647-conjugated goat anti-mouse (Invitrogen, A21311 or A31851 or A31852, 1:100). Alexa Fluor 488-or 647-conjugated streptavidin (Invitrogen, S32354 or S32357, 1:100) was used to recognize Biotinylated GSL I-isolectin B4.
In situ hybridization. In situ hybridization was performed on frozen sections as described previously (Wilkinson, 1999) . The digoxigenin RNA labeling and detection kit from Roche Biochemicals was used to generate RNA probes using a 200 bp integrin ␤8 cDNA fragment from exon 4 as template. Tissue sections were hybridized overnight with digoxigenin-labeled RNA probes (0.4 mg/ml) at 60oC, washed in 2ϫ SSC at 65oC, incubated with RNase (1 mg/ml in 2ϫ SSC), washed in 0.2ϫ SSC at 65°C, blocked in TBS with 10% sera, and incubated in alkaline phosphatase labeled anti-DIG antibody (Roche) (1:2000, 10% sera) overnight. Sections were incubated with NBT (nitroblue tetrazolium) and BCIP (5-bromo-4-chloro-3-indolyl-phosphate) (Roche) for the colorimetric detection of alkaline phosphatase activity. Staining was stopped after visual inspection. Sections were washed, fixed in 4% paraformaldehyde, and coverslipped.
Imaging. Confocal imaging was performed on a Zeiss LSM5 Pascal microscope.
Measurements and statistics. All quantifications were done using highresolution confocal images representing a thin optical section of the sample. Images were analyzed using ImageJ software using previously reported guidelines (Pitulescu et al., 2010) . Each group contained at least three mutants and three littermate controls; four images from each retina (one image in each quadrant) was used to analyze angiogenic parameters. The number of branchpoints and the percentage area covered by CD31-positive endothelial cells were calculated from fields sized 460 ϫ 230 m using images from the central vascular plexus in the area between an artery and vein, without the angiogenic front. The number of Collagen IV-positive stained, isolectin B4-negative stained sleeves were counted in fields sized 230 ϫ 230 m from the central vascular plexus in an area between an artery and vein, without the angiogenic front. PhosphoHistone 3 labeled CD31-positive endothelial cells were counted in fields sized 460 ϫ 460 m from the angiogenic front. Quantification of phospho-SMAD3 immunofluorescent staining was determined using stained cryosections from three mutants and three controls at P9. Three randomly chosen confocal images from each sample were taken using the same confocal settings. ImageJ software was used to quantify the number of endothelial cell nuclei (ToPro3-positive, CD31-positive) per total CD31-positive vessel length per image, and the intensity of phospho-SMAD3 staining in each endothelial cell nuclei. p-values were defined using Student's t test for paired comparisons and ANOVA for group-wise comparisons with Tukey's post hoc test analysis to compare individual groups. Control groups from experiments with ␤8icr, ␤8nesCre, and ␤8mGFAPcre mice ( Fig. 1 ; see Fig. 3 ), and TGF␤1 and TGF␤RII mice (see Fig. 4 ) were not significantly different in any parameter measured, and were therefore grouped together and used as a collective "control."
Results
To examine the role of the Itgb8 gene in retinal vascular development, we first characterized the phenotype resulting from Itgb8 gene deletion throughout the animal, including all cells of the retina. For this, we used our original Itgb8 knock-out, outbred onto the ICR background (␤8icr Ϫ/Ϫ ) to permit survival into adulthood (Zhu et al., 2002; Lakhe-Reddy et al., 2006) . Results, presented in Figure 1 , show that complete Itgb8 deletion results in hemorrhage within the retina at P6 (Fig. 1 A) . Vascular organization in the superficial (primary) plexus at the level of the retinal ganglion cell layer is highly abnormal with excessive branching and increased vessel coverage of the retinal surface ( Fig. 1 B, F ) . The stability of the developing vasculature appears to be significantly reduced, as assessed by the presence of collagen IV segments lacking endothelial cells (Fig. 1C,F ) . Formation of the superficial vascular plexus appears to be transiently delayed in Itgb8 mutants (data not shown), but the densities and morphologies of vascular tip cells appear comparatively normal (Fig. 1 D) . Consistent with our prior observations within the CNS (Zhu et al., 2002) , mutant retinal endothelial cells have an abnormally high rate of proliferation ( Fig. 1 E, F ) and a very low level of apoptosis, not different from that in controls (data not shown). In addition, complete loss of Itgb8 resulted in no apparent alteration in pericyte coverage as assessed by colocalization of several pericyte-specific markers-␣-smooth muscle actin (␣SMA), NG2 and desmin ( Fig. 2 A-C) . Normal expression of the arterial and arteriolar marker ephrinB2-eGFP in conditional Itgb8;nesCre mutants (see below) suggests that absence of this integrin does not prevent normal arterial-venous differentiation (Fig.  2 D) (Wang et al., 1998; Adams and Klein, 2000) . Thus, development of the superficial vascular plexus is not prevented by the absence of the integrin ␣V␤8, but the plexus appears unstable and exhibits other abnormalities that are likely to be the cause of hemorrhage.
Following initial formation of a superficial vascular plexus at the level of the retinal ganglion cell layer, vessels sprout into the depth of the retina, growing along Müller glial cell processes, and establish two deep vascular plexuses (see diagrams, Fig. 3 A, B) . Ϫ/Ϫ and ␤8;nesCre mutants compared with ␤8;mGFAPCre mutants and controls. C, Vascular endothelia (IB4) and collagen IV staining demonstrate elevated numbers of collagen IV sleeves lacking endothelia (arrows) in ␤8icr Ϫ/Ϫ and ␤8;nesCre mutants compared with ␤8;mGFAPCre mutants and controls. D, Images of angiogenic front in the control and three mutants reveals no overt differences in tip cell or filopodial morphology. E, Panels from P6 control, Itgb8 complete knock-out (␤8icr Ϫ/Ϫ ) and nesCre-specific Itgb8 (␤8;nesCre) mutant retinas colabeled with anti-CD31 (endothelia) and anti-phospho-histone H3 (PH3, proliferating cells). Endothelial proliferation was not analyzed in ␤8;mGFAPCre mutants. F, Quantifications of vascular branch point density (number per 0.106 mm 2 field), vessel coverage (percentage of area covered by CD31-expressing endothelial cells), empty collagen IV sleeves as illustrated in C (number per 0.0529 mm 2 field), and endothelial cell proliferation (number of proliferating (PH3ϩ), CD31ϩ endothelial cells per field as illustrated in E) demonstrate significant differences between control and ␤8icr Ϫ/Ϫ or ␤8;nesCre mutants, but no significant difference between control and ␤8;mGFAPCre mutants [ANOVA p-values Ͻ 0.0005; Tukey's subgroup analysis: *p Ͻ 0.05, **p Ͻ 0.005, ***p Ͻ 0.0005, NS ϭ not significant. N ϭ 16 (combined controls), N ϭ 4 (␤8icr Ϫ/Ϫ , ␤8;nesCre), N ϭ 3 (␤8;mGFAPCre)]. Error bars represent SEM.
The outer deep vascular plexus first forms at the outer boundary of the inner nuclear layer by P9, followed by the inner deep vascular plexus which forms at the inner boundary of the inner nuclear layer by P14. When we compared development of the outer deep vascular plexus at P9 and P14 in control and Itgb8 mutant retinas, we observed that its formation is dramatically impaired in the mutant (Fig. 3 A, B) . Thus, integrin ␣V␤8 appears to be required for development of this plexus. In contrast, Itgb8 deletion does not prevent development of the inner deep vascular plexus. The vessels in the inner deep vascular plexus, however, are clearly abnormal, most obviously being thicker than in the control.
In prior work to identify the cells that must express integrin ␣V␤8 to prevent hemorrhage within the developing dorsal forebrain, we demonstrated through use of cell-specific Itgb8 knock-outs that expression of this integrin is required in the neuroepithelium and astroglia, but not within neurons or endothelial cells (Proctor et al., 2005) . Analysis of cell-specific itgav knock-outs resulted in the same conclusion (McCarty et al., 2005) . We therefore hypothesized that loss of Itgb8 expression from retinal glial populations (astrocytes and/or Müller glia) would also disrupt the developing retinal vasculature, similar to our observations in the complete Itgb8 knock-out. To explore this, we used two different cre transgenes: the nesCre transgene, which promotes Cre-mediated recombination in CNS neuroglial precursors starting at E8.5 (Petersen et al., 2002) , and the mGFAP-driven Cre 73.12 transgene (Garcia et al., 2004) , which efficiently recombines brain astrocytes. As shown in Figure 1A , nesCre-mediated deletion of Itgb8 virtually phenocopied mutants with complete loss of Itgb8 (␤8icr Ϫ/Ϫ ), displaying highly disorganized and unstable vasculature with excessive branch points, increased vessel coverage, increased empty collagen IV sleeves, and hemorrhage. Endothelial cells of the superficial vascular plexus had abnormally high levels of proliferation (Fig. 1E,F) . Formation of the outer deep vascular plexus in ␤8nesCre (Itgb8;nesCre) mutants was severely disrupted (data not shown). As with ␤8icr mutants, conditional ␤8nesCre mutants had comparatively normal tip cells (Fig.  1D ) as well as normal arteriovenous differentiation, and pericyte recruitment (Fig. 2) . Surprisingly, when Itgb8 was deleted using the mGFAPCre transgene, the retinal vasculature appeared to be very similar to that in control retinas, with no hemorrhage or abnormalities in vessel coverage or branch point density (Fig. 1) . While the data suggest that there may be an elevated number of empty collagen IV segments in this mutant, the difference was not statistically significant.
To better understand the difference in phenotypes between ␤8nesCre and ␤8mGFAPCre mutants, we examined expression of itgb8 mRNA within the P6 retina by in situ analysis (Fig. 4 A) .
For this purpose, we examined expression of Itgb8 exon 4, the exon flanked by loxP sites in the conditional itgb8 mutant (Proctor et al., 2005) . In situ hybridization for Itgb8 mRNA demonstrates strong expression of Itgb8 in the inner nuclear layer, ganglion cell layer, and nerve fiber layer, consistent with expression in Müller glia cell bodies, descending processes, and endfeet, respectively, as well as retinal ganglion cells. Notably, expression of Itgb8 exon 4 is completely abolished by nesCre-mediated recombination, arguing that expression of ␣V␤8 is limited to cells-neurons or glia-targeted by nesCre.
To further examine the cellular specificity of the nesCre and mGFAPCre lines, we used two different reporters-Rosa26;tdTomato;Ai14 (Madisen et al., 2010) and R26R-EYFP (Srinivas et al., 2001) . Results using each reporter, presented in Figure 4 , B and C, show that nesCre mediates recombination in a large majority of neural and glial cells within the retina, including but not restricted to nestin-, glutamine synthetase-, and CRALBPexpressing Müller Glia (Close et al., 2005) . Interestingly, data using the EYFP reporter show that nesCre does not promote detectable recombination in GFAP-expressing retinal astrocytes (Fig. 4C) , even though these cells migrate into the eye from the optic nerve (Watanabe and Raff, 1988) . In contrast, our data show that the mGFAP-driven Cre 73.12 transgene promotes efficient recombination in GFAP-expressing astrocytes, but not within nestin-expressing Müller glia (Fig. 3C,D) . Together with the in situ data that indicated that nesCre-mediated recombination virtually eliminated itgb8 expression within the retina (Fig.  4 A) , the results argue that retinal astrocytes do not play a significant role in ␣V␤8-mediated vascular development. The complete loss of itgb8 mRNA expression observed following nesCre-mediated recombination indicates that GFAPexpressing astrocytes do not express significant levels of ␣V␤8. Together with prior observations within the CNS that excluded a neuronal role in ␣V␤8-mediated signaling (Proctor et al., 2005) , our results suggest that ␣V␤8 expression on Müller glia is required for formation of a normal and stable vascular plexus and to prevent hemorrhage.
As summarized in the introduction, there is compelling evidence that a major role of integrin ␣V␤8 in vivo is to facilitate release of active TGF␤ from large and small latent TGF␤-containing inactive complexes (Mu et al., 2002; Aluwihare et al., 2009) . To obtain direct evidence that the presence of integrin ␣V␤8 promotes TGF␤ signaling within the developing retina, we quantified phospho-SMAD3 levels in vessel-associated nuclei in control and Itgb8 mutant retinas. Results (Fig. 5 A, B) show that elevated numbers of endothelial cells, identified through colabeling with the endothelial cell marker CD31, are present in the mutant retina. This is consistent with data above demonstrating elevated endothelial cell proliferation in the Itgb8 mutant. When phospho-SMAD3 levels within each endothelial cell nucleus were quantified, however, significantly less phospho-SMAD3 was observed in each of the mutant nuclei (Fig. 5 A, B) . On balance, these observations indicate that absence of the integrin ␣V␤8 results in reduced TGF␤ signaling within endothelial cells.
To strengthen this conclusion, we examined the phenotypes with in the retina of mice lacking TGF␤1 ligand (Tgfb1 Ϫ/Ϫ mutant). In results presented in Figure 6 , we observed the presence of hemorrhage and a highly abnormal vasculature in this mutant. The superficial vascular plexus in this mutant exhibited an elevated density of branch points, elevated coverage of the retinal surface and increased proliferation of the endothelial cells. The vasculature also appeared to be unstable as documented by increased numbers of collagen IV sleeves lacking endothelial cells. These observations indicate that mice lacking TGF␤1 ligand exhibit retinal vascular phenotypes very similar to those observed in the ␤8icr Ϫ/Ϫ and ␤8nesCre conditional mutants (Fig. 1) . To provide direct evidence that TGF␤ signaling within endothelial cells is required for normal vascular development within the retina, we examined retinas in mice with conditional deletion from endothelial cells of the gene encoding the essential TGF␤ receptor, TGF␤RII. This receptor subunit is required for both Alk1 and Alk5 (type I TGF␤ receptors)-mediated TGF␤ signal transduction (Schmierer and Hill, 2007) . To examine the likely involvement of endothelial cells, we deleted Tgfbr2 by crossing Tgfbr2 flox mice with inducible platelet-derived growth factorBCre-ER TM2 mice (Levéen et al., 2002; Claxton et al., 2008) . A tamoxifen-dependent Cre was used for these experiments because the constitutive absence of TGF␤RII in endothelial cells results in early embryonic lethality due to cardiovascular deficits (Jiao et al., 2006; Carvalho et al., 2007; Robson et al., 2010) . To promote postnatal Tgfbr2 deletion, newborn pups were injected with tamoxifen at P1, P2, and P3. Conditional recombination was followed in mutant and control animals with the Rosa26; tdTomato;Ai14 Cre reporter (Madisen et al., 2010) . When the superficial vascular plexus was examined at P6, the mutant showed a very similar phenotype to that observed in the complete absence of retinal ␣V␤8 or TGF␤1 including prominent retinal hemorrhage (Fig. 6 A) . In addition, the mutant retinas formed vascular plexuses with an abnormally high density of branches and elevated coverage of the retinal surface by the vasculature (Fig. 6 A, B) . Proliferation of endothelial cells was abnormally high in the mutant (Fig. 6 B) . The increased density of collagen IV sleeves lacking endothelial cells indicated that vascular stability was reduced (Fig. 6 A, B) . As in the Itgb8 and Tgfb1 mutants, the apparently normal association of ␣-smooth muscle actin and NG2-expressing cells suggests that pericyte coverage of the vas- culature was comparatively normal (Fig. 6 A) and the density and morphology of endothelial tip cells at the angiogenic front appeared similar in both the control and mutant retinas (Fig. 6 A) . Thus, endothelial cells appear to be an essential target for integrin ␣V␤8-dependent TGF␤ signaling that facilitates formation of a normal superficial vascular plexus.
To examine the potential role of endothelial cell TGF␤ signaling in promoting vessel stability after formation, and in the formation of the deep vascular plexus, we examined Tgfb1 and conditional endothelial cell-specific Tgfrb2 flox mutants, the latter initiated by tamoxifen injections into pups at P5 and P6. When the retinas were examined at P9, the preestablished superficial vascular plexus appeared to be disrupted with tortuous vessel segments and associated hemorrhage (Fig. 6C,D) . In addition, the outer deep vascular plexus in the outer portion of the inner nuclear layer was virtually absent (Fig. 6C,D) in both mutants. As with the ␤8icr Ϫ/Ϫ and ␤8nesCre mutants, the inner deep vascular plexus of Tgfb1 mutants developed by P14, but the outer deep plexus did not form. Even though the inner deep vascular plexus does form, it was clearly abnormal with vessels much thicker than those present in the control. (Endothelial cell-specific Tgfbr2 mutants were significantly smaller than controls at P14, and were therefore not studied at this time point.) Thus, these results, together with the requirement for integrin ␣V␤8, indicate that integrin ␣V␤8 promotes release of active TGF␤1, which then signals through endothelial cells to promote primary angiogenesis and vascular stabilization in the retina.
Discussion
Results presented in this paper show that absence in the developing retina of integrin ␣V␤8 as a result of Itgb8 gene deletion results in major abnormalities in retinal vessel formation, includ- . C, Panels depict overlap of endogenous nestin with that of the nesCre-eYFP reporter. Arrowheads point to recombined Müller glial endfeet wrapping around blood vessels (unstained). Note absence of overlap of endogenous GFAP present in retinal astrocytes with the eYFP reporter. Arrow points to an exemplary astrocyte cell body labeled by GFAP, but lacking eYFP recombination marker. Note that because nesCre promotes recombination in progenitors of many retinal cells in addition to Müller Glia, there is extensive expression of the eYFP reporter in cells that do not express nestin. Right panels depict overlap of endogenous GFAP (red) with mGFAPCre (mGfap-Cre73.12)-mediated recombination as visualized using the RosaR26-eYFP reporter (green). Arrow points to an astrocyte cell body labeled by GFAP with strong overlapping eYFP recombination marker. D, Fibers of Müller glia extend into the deeper retina and are recombined by nesCre, whereas there are no GFAP-staining astrocyte fibers in this layer, and no recombination from the mGFAPcre transgene in this layer. Scale bars, 50 m.
ing increased endothelial proliferation, elevated vascular branching, reduced vasculature segment stability and hemorrhage. In addition, absence of this integrin severely compromised formation of the deep vascular plexus. In contrast, endothelial tip cells in the primary plexus and pericyte coverage of the nascent vessels in this plexus appeared comparatively normal. Thus, absence of ␣V␤8 appears to affect primarily reorganization and maturation of endothelial cells within the primary plexus, although it clearly has a more dramatic effect on the formation of the outer deep vascular plexus.
The phenotype of the Itgb8 mutant is mimicked by neuroepithelial-specific deletion of Itgb8 using the nesCre transgene, indicating that TGF␤ is mostly likely activated by ␣V␤8 on surfaces of neuroepithelial cells and Müller glia. Indeed, we see intense staining for Itgb8 mRNA in a distribution similar to that of Müller glial cell bodies and processes, which is entirely lost in the conditional ␤8nesCre mutants. Interestingly, retinal astrocytes do not appear to have an essential role in controlling TGF␤ signaling because hemorrhage and vascular abnormalities are not observed following specific deletion of Itgb8 gene deletion within these cells, using mGFAPCre. These cells seem unlikely to express significant levels of ␣V␤8 because expression of Itgb8 mRNA appears to be almost absent from the retina in the conditional ␤8nesCre mutant, despite the presence of a normal Itgb8 gene within GFAP-expressing astrocytes,. Thus, it is not surprising that the presence of a normal Itgb8 gene within retinal astrocytes does not prevent the vascular abnormalities observed in the ␤8; nesCre mutant.
Our observations are consistent with the observed colocalization of integrin ␤8 with markers of radial glia in a perivascular distribution in the developing CNS (Cambier et al., 2005) . With their close apposition to developing blood vessels of both the superficial vascular plexus and the penetrating vessels which form the deep vascular plexus, retinal Müller glia are well positioned to provide important paracrine signaling effectors such as VEGF or TGF␤. Indeed, Müller glia are known to secrete various growth factors involved in both physiologic and pathologic retinal angiogenesis (Harada et al., 2005 (Harada et al., , 2011 Ye et al., 2009 Ye et al., , 2011 . Our observations on the apparently minor importance of astrocyte ␣V␤8 are similar to those indicating that retinal astrocytederived VEGF is also relatively dispensable during development (Scott et al., 2010) .
Another major finding of the present study is that levels of phospho-SMAD3 within endothelial cell nuclei are reduced significantly in the Itgb8 mutant compared with control endothelial cells, providing direct evidence that absence of this integrin impairs TGF␤ signaling within the developing vasculature. This result is entirely consistent with recent evidence showing that in cell culture, astroglial-derived ␣V␤8 binds to and activates latent TGF␤1 and 3, which then transactivates brain endothelial cells (Mu et al., 2002; Cambier et al., 2005) ; with the immunohistochemical localization of TGF␤1 and 3 in perivascular basement membranes of the retina (Lutty et al., 1993) ; and with work that demonstrates an essential role for TGF␤ signaling in maintaining developmental and adult retinal microvascular homeostasis and barrier function (Walshe et al., 2009; Mahmoud et al., 2010) . Moreover, we show that the vascular phenotypes found in Itgb8 mutants are also observed following abolition of TGF␤ signaling in retinal endothelial cells through tamoxifen-induced, Cremediated deletion of the essential TGF␤ receptor subunit, TGF␤RII. These previous studies, and this current work therefore establish that ␣V␤8-mediated activation of TGF␤ signaling in endothelial cells in vivo has an essential role in enhancing vascular maturation and stability within the developing retina. This work also suggests that ␣V␤8-TGF␤ signaling could play an important role in vascular patterning and barrier formation in various developmental and pathological contexts outside of the retina.
Overall these results are consistent with, but extend our prior studies on the role of this integrin in CNS vascular development. In prior work, we showed that loss of Itgb8 leads to vascular dysplasia and hemorrhage in the brain (Zhu et al., 2002) . These effects were specific to integrin ␣V␤8 expressed in neuroepithelial cells and radial glia, as neuroepithelial deletion of integrin ␣V␤8 completely recapitulates the Itgb8 KO brain phenotype. In contrast, Itgb8 deletion from brain astrocytes, microglia, pericytes, postmitotic neurons, or endothelial cells, did not result in an obvious vascular deficit (Proctor et al., 2005; our unpublished observations) . Our present studies extend this work by providing a direct demonstration that canonical TGF␤ signaling is reduced in the mutant vasculature as well as showing the importance of this integrin within the developing retina.
The retinal vascular phenotypes resulting from loss of ␣V␤8-TGF␤1 signaling, and in particular the loss of outer deep vascular Ϫ/Ϫ and endothelial-specific Tgfbr2 mutant (TGF␤RII;i⌬EC) P6 retinas. TGF␤RII;i⌬EC mutant retinas were generated using animals homozygous for the Tgfbr2-flox allele bearing also a Pdgfb promoter-regulated Cre-ER-T2 transgene. Cre recombination was induced by intragastric tamoxifen injections (50 g) at P1, P2, and P3. Loss of TGF␤1 or TGF␤RII results in hemorrhage at P6 as illustrated by extravascular red blood cells (Ter119) in the mutant retinas (left panels). Endothelial cells, visualized by endothelial cell-specific expression of tdTomato (Pdgfb-CreER TM2 -mediated expression of recombination marker tdTomato from Rosa26RtdTomato;AI14 allele) and/or CD31 labeling illustrate enhanced vascular branching density in P6 Tgfb1 plexus formation, are similar to those seen in several other mouse mutants. Of note, Ang2-defient mice (Hackett et al., 2000 (Hackett et al., , 2002 ; mice with defective Norrin/Frizzled-4/Lrp5 signaling (Ye et al., 2009 ); mice with defective Jagged1/Dll4/Notch signaling (Benedito et al., 2009) ; and mice with defective neuropilin-1 signaling (Pan et al., 2007) all lack formation of the outer deep vascular plexus. Neuropilin-1 is of particularly relevance to this study because its ligands include active and latent TGF␤ (Pan et al., 2007; Glinka and Prud'homme, 2008; Cao et al., 2010; Glinka et al., 2011) . Neuropilin-1 inhibition has been shown to increase vascular density within the primary vascular plexus and to severely impair formation of the deep vascular plexus with little effect on VEGF-RII signaling (Pan et al., 2007) . Within the CNS, the abnormal endothelial proliferation and organization seen in the neuropilin-1 mutant is strikingly similar to that observed in the Itgb8 mutant (Zhu et al., 2002; Gerhardt et al., 2004) . As recent data indicate that the neuropilins bind both latent and active TGF␤, facilitate TGF␤ activation, and control the balance of phosphorylation of different SMAD effectors of TGF␤ signaling (Glinka and Prud'homme, 2008; Cao et al., 2010; Glinka et al., 2011) , it is not clear precisely how ␣V␤8 and neuropilin signaling intersect in the retina. As ␣V␤8 binding alone does not appear sufficient to activate latent TGF␤ complexes (Mu et al., 2002) , it is possible that neuropilin is required for latent complex activation, perhaps through generation of tension (Shi et al., 2011) .
Together, our findings suggest a novel paradigm for coupling neuroglia cells to blood vessels during development through ␣V␤8-TGF␤ signaling. Considering the already well characterized role for TGF␤ in angiogenic pathologies, it is tempting to speculate that ␣V␤8 may play parallel roles in human gliovascular diseases. Angiogenesis and associated vessel instability are hallmark features of retinopathy of prematurity and proliferative diabetic retinopathy. Intriguingly, TGF␤ is dysregulated in both human and experimental retinopathy of prematurity (Shih et al., 2003; Drenser, 2009) . Similarly, genetic polymorphisms in TGF␤1 are associated with increased risk for proliferative diabetic retinopathy (Beránek et al., 2002) . TGF␤ levels are altered in both human and experimental proliferative diabetic retinopathy (Pfeiffer et al., 1997; Gerhardinger et al., 2009) , and systemic TGF␤ blockade in adult mice disrupts retinal vessel architecture and barrier function, reminiscent of pathological changes associated with proliferative diabetic retinopathy (Walshe et al., 2009) . Finally, some studies show that selective inhibition of integrin ␣V, ␤8's only known dimerization partner, significantly attenuates neo-angiogenesis in experimental proliferative retinopathies (Chavakis et al., 2002) . Selective inhibition of integrin ␤8 in these settings might similarly affect pathological retinal angiogenesis.
Note added in proof. A related paper was published recently after the submission of our revised manuscript (Hirota et al., 2011) . Both papers used nestin-driven Cre expression to delete Itgb8 within the retinal precursor cells and observed similar retinal hemorrhagic phenotypes. Harada et al. (2011) report a deficit in tip cell filopodia density not observed in our study. The authors did not include a description of the abnormalities in vascular branch point density, coverage, or stability that were observed in our study. Both papers provide data that strongly supports a role of this integrin in development of the secondary (deep) vascular plexus. Hirota et al. (2011) did not examine the role in the outer versus inner deep vascular plexus. Retinal anti-TGF injection by Hirota et al. (2011) provided data complementary to ours on the role of TGF as a downstream effector of this integrin. The most important disagreement between our papers concerns the role of V8 in retinal astrocytes versus Müller glia. Hirota et al. (2011) concluded that retinal astrocyte-expressed V8 is required for normal retinal angiogenesis because they observed expression of this integrin in cultured retinal astrocytes. Our data indicates that nestin-Cre promotes efficient gene deletion in Müller glia, but not retinal astrocytes in vivo. We also observed expression of the 8 subunit in Müller glia, but not retinal astrocytes in vivo. Following astrocyte-specific, GFAP-Cre-mediated Itgb8 deletion in vivo, we did not detect retinal hemorrhage or significant abnormalities in vascular branching, coverage, or stability. It seems likely that the cultures examined by Hirota et al. (2011) contained Müller glia that mediated TGF activation.
